Your browser doesn't support javascript.
loading
The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease.
Hasholt, Lis; Ballegaard, Martin; Bundgaard, Henning; Christiansen, Michael; Law, Ian; Lund, Allan M; Norremolle, Anne; Krogh Rasmussen, Ase; Ravn, Kirstine; Tumer, Zeynep; Wibrand, Flemming; Feldt-Rasmussen, Ulla.
Afiliação
  • Hasholt L; a Section of Neurogenetics, Department of Cellular and Molecular Medicine , Copenhagen University , Denmark.
  • Ballegaard M; b Department of Neurophysiology , Rigshospitalet, Copenhagen University , Denmark.
  • Bundgaard H; c Unit for Inherited Cardiac Diseases, Department of Cardiology , Rigshospitalet, Copenhagen University , Denmark.
  • Christiansen M; d Department for Congenital Disorders , Statens Serum Institut , Denmark.
  • Law I; e Departments of Nuclear Medicine , Rigshospitalet, Copenhagen University , Denmark.
  • Lund AM; f Clinical Genetics , Rigshospitalet, Copenhagen University , Denmark.
  • Norremolle A; a Section of Neurogenetics, Department of Cellular and Molecular Medicine , Copenhagen University , Denmark.
  • Krogh Rasmussen A; g Medical Endocrinology , Rigshospitalet, Copenhagen University , Denmark.
  • Ravn K; f Clinical Genetics , Rigshospitalet, Copenhagen University , Denmark.
  • Tumer Z; a Section of Neurogenetics, Department of Cellular and Molecular Medicine , Copenhagen University , Denmark.
  • Wibrand F; f Clinical Genetics , Rigshospitalet, Copenhagen University , Denmark.
  • Feldt-Rasmussen U; g Medical Endocrinology , Rigshospitalet, Copenhagen University , Denmark.
Scand J Clin Lab Invest ; 77(8): 617-621, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29037082
Fabry disease is an X- linked inherited lysosomal storage disease caused by mutations in the GLA gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A). The possible pathological significance of the D313Y variant in the GLA gene has not been verified and it may be a Fabry variant. Our aim was to elucidate whether the presence of the D313Y variant influenced the α-Gal A activity or resulted in Fabry symptoms or Fabry organ involvement. In two Danish families the presence of the D313Y variant did not result in reduced α-Gal A activity or clinical Fabry manifestations in males, and the presence in Fabry females did not significantly enhance the phenotype of a known causative mutation in the GLA gene (G271S). Our findings indicate that the D313Y variant is not causative to nor enhancing Fabry disease phenotype. The D313Y variant in the GLA gene was not disease causative in 2 Danish families. Investigating male family members were crucial in excluding the Fabry phenotype, and thus very important for proper genetic counceling of all family members, as well as overdiagnosing a devastating genetic disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Fabry / Alfa-Galactosidase / Mutação de Sentido Incorreto Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Fabry / Alfa-Galactosidase / Mutação de Sentido Incorreto Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article